subscribeSubscribe
price-trendAsk Us
Enforcement Report - Week of October 25, 2023

Enforcement Report - Week of October 25, 2023
FDA
25 Oct 2023
Share Share
Avet`s Generic Foscarnet Sodium Receives Approval in the U.S.

Avet`s Generic Foscarnet Sodium Receives Approval in the U.S.
FDA
05 Jun 2023
Share Share
Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older

Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
BUSINESSWIRE
02 Dec 2021
Share Share
Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more

Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more
BUSINESSWIRE
23 Nov 2021
Share Share
FDA`s ADAC unanimously backs Takeda`s drug for post-transplant cytomegalovirus

FDA`s ADAC unanimously backs Takeda`s drug for post-transplant cytomegalovirus
Z. Brennan ENDPTS
08 Oct 2021
Share Share
Phase 3 Trial Subgroup Analysis Across SOT Types Supports Efficacy of Maribavir

Phase 3 Trial Subgroup Analysis Across SOT Types Supports Efficacy of Maribavir
PRESS RELEASE
07 Jun 2021
Share Share
Gland Pharma Ltd`s Generic Foscarnet Sodium Receives Approval In US

Gland Pharma Ltd`s Generic Foscarnet Sodium Receives Approval In US
FDA
04 May 2021
Share Share
Clinigen makes foray into Japan

Clinigen makes foray into Japan
Bureau BIO SPECTRUM
18 Oct 2016
Share Share